Financial Disclosure Prof. Menon has stock ownership and has received research funding
from Abcodia Ltd, a UCL spinout company with an interest in biomarkers and commercial …

Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …

Ovarian cancer is the third most common gynaecological malignancy and the most lethal
worldwide. Most patients are diagnosed with advanced disease which carries significant …

Ovarian cancer (OC) is the most lethal gynaecological malignancy. The search for a widely
affordable and accessible screening strategy to reduce mortality from OC is still ongoing …

Mortality impact, risks, and benefits of general population screening for ovarian cancer: the
UKCTOCS randomised controlled trial. - PMC Back to Top Skip to main content NIH NLM Logo …

Objectives. In June 2011, the National Institute for Health and Care Excellence (NICE)
Decision Support Unit published a Technical Support Document (TSD) providing …

Background Ovarian cancer is the sixth most common cancer in UK women and can be
difficult to diagnose, particularly in the early stages. Risk-scoring can help to guide referral to …

Background. Parametric modeling of survival data is important, and reimbursement
decisions may depend on the selected distribution. Accurate predictions require sufficiently …

Abstract Background and Objective The extrapolation of estimated hazard functions can be
an important part of cost-effectiveness analyses. Given limited follow-up time in the sample …

Objectives Parametric models are routinely used to estimate the benefit of cancer drugs
beyond trial follow-up. The advent of immune checkpoint inhibitors has challenged this …